133 related articles for article (PubMed ID: 31776298)
1. GPI-80 as a Useful Index for Myeloid Cell Heterogeneity and a Potential Prognostic Biomarker for Metastatic Renal Cell Carcinoma.
Kato T; Takeda Y; Ito H; Kurota Y; Yamagishi A; Sakurai T; Naito S; Araki A; Nara H; Asao H; Tsuchiya N
Tohoku J Exp Med; 2019 Nov; 249(3):203-212. PubMed ID: 31776298
[TBL] [Abstract][Full Text] [Related]
2. The pattern of GPI-80 expression is a useful marker for unusual myeloid maturation in peripheral blood.
Takeda Y; Kato T; Ito H; Kurota Y; Yamagishi A; Sakurai T; Araki A; Nara H; Tsuchiya N; Asao H
Clin Exp Immunol; 2016 Dec; 186(3):373-386. PubMed ID: 27569996
[TBL] [Abstract][Full Text] [Related]
3. Initial Myeloid Cell Status Is Associated with Clinical Outcomes of Renal Cell Carcinoma.
Sabrina S; Takeda Y; Kato T; Naito S; Ito H; Takai Y; Ushijima M; Narisawa T; Kanno H; Sakurai T; Saitoh S; Araki A; Tsuchiya N; Asao H
Biomedicines; 2023 Apr; 11(5):. PubMed ID: 37238964
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of CC-chemokine receptor seven expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor.
Xia Y; Liu L; Xiong Y; Bai Q; Wang J; Xi W; Qu Y; Xu J; Guo J
BMC Cancer; 2017 Jan; 17(1):70. PubMed ID: 28114889
[TBL] [Abstract][Full Text] [Related]
5. Single-cell analysis reveals metastatic cell heterogeneity in clear cell renal cell carcinoma.
Liu K; Gao R; Wu H; Wang Z; Han G
J Cell Mol Med; 2021 May; 25(9):4260-4274. PubMed ID: 33759378
[TBL] [Abstract][Full Text] [Related]
6. Association of myeloid-derived suppressor cells and efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma patients.
Wang Z; Zhang Y; Liu Y; Wang L; Zhao L; Yang T; He C; Song Y; Gao Q
J Immunother; 2014 Jan; 37(1):43-50. PubMed ID: 24316555
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
8. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
[TBL] [Abstract][Full Text] [Related]
9. Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma.
Lucarelli G; Rutigliano M; Sanguedolce F; Galleggiante V; Giglio A; Cagiano S; Bufo P; Maiorano E; Ribatti D; Ranieri E; Gigante M; Gesualdo L; Ferro M; de Cobelli O; Buonerba C; Di Lorenzo G; De Placido S; Palazzo S; Bettocchi C; Ditonno P; Battaglia M
Medicine (Baltimore); 2015 Nov; 94(46):e2117. PubMed ID: 26579829
[TBL] [Abstract][Full Text] [Related]
10. Expression of Genes Involved in Cellular Adhesion and Extracellular Matrix Remodeling Correlates with Poor Survival of Patients with Renal Cancer.
Boguslawska J; Kedzierska H; Poplawski P; Rybicka B; Tanski Z; Piekielko-Witkowska A
J Urol; 2016 Jun; 195(6):1892-902. PubMed ID: 26631499
[TBL] [Abstract][Full Text] [Related]
11. Opposite prognostic roles of HIF1α and HIF2α expressions in bone metastatic clear cell renal cell cancer.
Szendrői A; Szász AM; Kardos M; Tőkés AM; Idan R; Szűcs M; Kulka J; Nyirády P; Szendrői M; Szállási Z; Győrffy B; Tímár J
Oncotarget; 2016 Jul; 7(27):42086-42098. PubMed ID: 27244898
[TBL] [Abstract][Full Text] [Related]
12. A Gene Signature of Survival Prediction for Kidney Renal Cell Carcinoma by Multi-Omic Data Analysis.
Hu F; Zeng W; Liu X
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739630
[TBL] [Abstract][Full Text] [Related]
13. A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients.
Vetsika EK; Koinis F; Gioulbasani M; Aggouraki D; Koutoulaki A; Skalidaki E; Mavroudis D; Georgoulias V; Kotsakis A
J Immunol Res; 2014; 2014():659294. PubMed ID: 25436215
[TBL] [Abstract][Full Text] [Related]
14.
Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S
DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241
[TBL] [Abstract][Full Text] [Related]
15. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
[TBL] [Abstract][Full Text] [Related]
16. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy.
Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J
Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323
[TBL] [Abstract][Full Text] [Related]
17. TGF-β-activated kinase-1: a potential prognostic marker for clear cell renal cell carcinoma.
Wei C; Lai YQ; Li XX; Ye JX
Asian Pac J Cancer Prev; 2013; 14(1):315-20. PubMed ID: 23534745
[TBL] [Abstract][Full Text] [Related]
18. Increase in CD14+HLA-DR -/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis.
Arihara F; Mizukoshi E; Kitahara M; Takata Y; Arai K; Yamashita T; Nakamoto Y; Kaneko S
Cancer Immunol Immunother; 2013 Aug; 62(8):1421-30. PubMed ID: 23764929
[TBL] [Abstract][Full Text] [Related]
19. High NUCB2 expression level represents an independent negative prognostic factor in Chinese cohorts of non-metastatic clear cell renal cell carcinoma patients.
Fu H; Zhu Y; Wang Y; Liu Z; Zhang J; Wang Z; Xie H; Dai B; Xu J; Ye D
Oncotarget; 2017 May; 8(21):35244-35254. PubMed ID: 27806328
[TBL] [Abstract][Full Text] [Related]
20. High CXCR4 expression correlates with sunitinib poor response in metastatic renal cancer.
D' Alterio C; Portella L; Ottaiano A; Rizzo M; Carteni G; Pignata S; Facchini G; Perdona S; Di Lorenzo G; Autorino R; Franco R; La Mura A; Nappi O; Castello G; Scala S
Curr Cancer Drug Targets; 2012 Jul; 12(6):693-702. PubMed ID: 22463589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]